Gilles Pialoux Selected Research

VaxSyn HIV-1 (gp160) vaccine

11/2008

Short communication: Long-term persistence of vaccine-induced HIV seropositivity among healthy volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gilles Pialoux Research Topics

Disease

17	Infections 10/2021 - 08/2004
16	HIV Infections (HIV Infection) 01/2022 - 12/2005
9	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 04/2006
7	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022 - 09/2012
6	Fibrosis (Cirrhosis) 01/2017 - 12/2005
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 02/2006
5	Hepatitis C 01/2017 - 05/2006
3	COVID-19 10/2022 - 01/2020
3	Inflammation (Inflammations) 03/2021 - 01/2019
2	Hypertension (High Blood Pressure) 12/2020 - 01/2019
2	Disseminated Intravascular Coagulation 12/2020 - 03/2019
2	Necrosis 03/2019 - 01/2018
2	Vasculitis (Vasculitides) 01/2015 - 04/2006
2	Hypersensitivity (Allergy) 06/2014 - 11/2005
2	Leukocytosis (Pleocytosis) 07/2013 - 03/2010
2	Malaria 07/2011 - 01/2005
2	Hepatitis 09/2010 - 08/2007
2	Hepatitis B 04/2010 - 01/2007
2	Viremia 03/2010 - 08/2004
2	Chronic Hepatitis C 08/2007 - 12/2004
1	Pneumonia (Pneumonitis) 04/2022
1	Abscess 01/2021
1	Lung Abscess 01/2021
1	Thrombosis (Thrombus) 12/2020
1	Thrombocytopenia (Thrombopenia) 12/2020
1	Lymphopenia (Lymphocytopenia) 12/2020
1	Obesity 12/2020
1	Cognitive Dysfunction 05/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Fatigue 01/2020
1	Reinfection 01/2020
1	Immune System Diseases (Immune Disorders) 11/2019
1	Ischemia 03/2019
1	Multiple Organ Failure (MODS) 03/2019
1	Meningococcal Infections 03/2019
1	Meningococcal Meningitis 03/2019
1	Meningitis 03/2019
1	Purpura Fulminans 03/2019
1	Frailty 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2018

Drug/Important Bio-Agent (IBA)

10	RNA (Ribonucleic Acid)IBA 01/2020 - 05/2006
6	Tenofovir (Viread)FDA Link 10/2021 - 06/2013
6	VaccinesIBA 11/2019 - 04/2006
6	Ribavirin (Virazole)FDA LinkGeneric 01/2015 - 12/2004
5	Pharmaceutical PreparationsIBA 01/2021 - 08/2007
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2019 - 07/2014
5	InterferonsIBA 07/2014 - 12/2004
4	Emtricitabine (Emtriva)FDA Link 10/2021 - 07/2014
4	Maraviroc FDA Link 01/2017 - 06/2014
3	Antiviral Agents (Antivirals)IBA 01/2021 - 10/2019
3	AntibodiesIBA 01/2020 - 01/2007
3	RacivirIBA 10/2018 - 12/2015
3	AntigensIBA 10/2018 - 07/2011
2	Doxycycline (Periostat)FDA LinkGeneric 10/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 03/2019 - 03/2010
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 11/2015 - 03/2015
2	Raltegravir Potassium FDA Link 06/2014 - 10/2009
2	Proteins (Proteins, Gene)FDA Link 07/2013 - 03/2010
2	CytokinesIBA 07/2011 - 03/2006
2	Antimalarials (Antimalarial Agents)IBA 07/2011 - 01/2005
2	LipopeptidesIBA 03/2008 - 04/2006
2	Interferon alpha-2 (Roferon-A)FDA Link 05/2006 - 12/2004
2	Didanosine (Videx)FDA LinkGeneric 12/2005 - 12/2004
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2022
1	sotrovimabIBA 10/2022
1	Oxygen (Dioxygen)IBA 04/2022
1	tocilizumab (atlizumab)FDA Link 04/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022
1	Darunavir (Prezista)FDA Link 01/2022
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 01/2022
1	IntegrasesIBA 01/2022
1	dolutegravirIBA 01/2022
1	Azithromycin (Zithromax)FDA LinkGeneric 10/2021
1	FluoroquinolonesIBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 12/2020
1	Protein CIBA 12/2020
1	Fibrinogen (Factor I)FDA Link 12/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	fostemsavirIBA 01/2020
1	grazoprevirIBA 01/2020
1	elbasvirIBA 01/2020
1	Vasodilator Agents (Vasodilators)IBA 03/2019
1	Dacarbazine (DIC)FDA LinkGeneric 03/2019
1	Biological ProductsIBA 03/2019
1	Reverse Transcriptase InhibitorsIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	NucleosidesIBA 01/2019
1	Integrase InhibitorsIBA 01/2019
1	TabletsIBA 01/2018
1	intrinsic factor-cobalamin receptorIBA 01/2018
1	Coffee FDA Link 01/2018
1	poly(1,2-ethylenepiperidine) N-oxideIBA 01/2018

Therapy/Procedure

19	Therapeutics 03/2021 - 08/2003
12	Highly Active Antiretroviral Therapy (HAART) 01/2018 - 08/2003
2	Condoms (Condom) 01/2017 - 12/2015
1	Artificial Respiration (Mechanical Ventilation) 04/2022
1	Injections 01/2022
1	Aftercare (After-Treatment) 01/2020